Arrowhead Pharmaceuticals, Inc. (ARWR)

72.80 -5.14 (-6.60%) USD  |  NASDAQ  |  May 08, 16:00
73.93 +1.12 (+1.55%) After-Hours: 19:47
More

Arrowhead Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
Biogen, Inc. Upgrade
Merck & Co., Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade